MK-4827 tosylate
99%
- Product Code: 101453
CAS:
1038915-73-9
| Molecular Weight: | 492.59 g./mol | Molecular Formula: | C₁₉H₂₀N₄OC₇H₈O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
MK-4827 tosylate is primarily utilized in the field of oncology research due to its role as a potent and selective inhibitor of PARP1 and PARP2 enzymes. These enzymes are involved in DNA repair mechanisms, and inhibiting them can be particularly effective in targeting cancer cells with defective DNA repair pathways, such as those with BRCA mutations. The compound is often employed in preclinical studies to evaluate its efficacy in inducing synthetic lethality in cancer cells, thereby enhancing the effectiveness of chemotherapy and radiation therapy. Additionally, MK-4827 tosylate is used to explore its potential in combination therapies, where it may improve outcomes by sensitizing tumor cells to other anticancer agents. Its application extends to understanding the broader role of PARP inhibition in various types of cancers, aiding in the development of targeted therapeutic strategies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿5,841.00 |
+
-
|
MK-4827 tosylate
MK-4827 tosylate is primarily utilized in the field of oncology research due to its role as a potent and selective inhibitor of PARP1 and PARP2 enzymes. These enzymes are involved in DNA repair mechanisms, and inhibiting them can be particularly effective in targeting cancer cells with defective DNA repair pathways, such as those with BRCA mutations. The compound is often employed in preclinical studies to evaluate its efficacy in inducing synthetic lethality in cancer cells, thereby enhancing the effectiveness of chemotherapy and radiation therapy. Additionally, MK-4827 tosylate is used to explore its potential in combination therapies, where it may improve outcomes by sensitizing tumor cells to other anticancer agents. Its application extends to understanding the broader role of PARP inhibition in various types of cancers, aiding in the development of targeted therapeutic strategies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :